Standards & Compliance
Thai GACP Foundation & EU-GACP Progression
TM Biomed’s long-term quality direction is centred on progressing from a Thai GACP cultivation foundation toward EU-GACP requirements, supporting future collaboration with qualified, regulated international partners.
Strategic Quality Direction
Our Quality Roadmap
We recognise that international medical markets require disciplined documentation, controlled operational processes, and clear alignment with the expectations of qualified downstream partners.
Thai GACP Cultivation Foundation
Establishing the baseline operational practices, consistency, and internal review processes required for professional agricultural controls.
EU-GACP Readiness Development
Actively advancing standard operating procedures and documentation systems to bridge the gap toward European regulatory expectations.
Partner-Specific Documentation Review
Tailoring documentation and compliance information exchanges to match specific jurisdictional requirements during B2B assessments.
EU-GMP Partnership Alignment
TM Biomed seeks dialogue with qualified companies operating under EU-GMP or comparable regulated quality systems. Partner requirements are reviewed case by case.
Documentation & Traceability
How We Approach Quality Documentation
Structured documentation is central to our long-term readiness for regulated international markets. Our approach is built around three core areas.
STEP 1
Cultivation Records
Maintaining structured records of cultivation practices, inputs, and internal review checkpoints consistent with Thai GACP principles.
STEP 2
Post-Harvest Handling
Documenting handling, drying, and storage processes to support consistency and traceability from cultivation through to partner review.
STEP 3
Partner-Facing Review
Preparing documentation packages tailored to the specific regulatory and quality expectations of each qualified counterparty.
Working With Us
Our Partner Assessment Process
We follow a structured, case-by-case process to assess potential alignment with qualified counterparties before moving into detailed technical or commercial discussion.
01
Initial Enquiry Review
We review submitted business information to confirm regulatory alignment and business fit.
02
Early Engagement Discussion
Both parties assess quality, documentation, and commercial requirements before formal review begins.
03
Documentation & Due Diligence
Where appropriate, detailed documentation is exchanged under confidentiality and due-diligence arrangements.
EU-GACP certification remains in progress. No certification, export approval, product availability, or regulatory suitability is represented through this website. TM Biomed does not represent itself as EU-GACP or EU-GMP certified.